
Claims data show regorafenib is prescribed earlier than guidelines advise for a good share of patients with advanced GIST, with dosing also varying widely.
America’s seniors are benefiting from a star rating system that ranks the quality of Medicare Advantage plans, according to a study published in the Journal of the American Medical Association.
Authors affiliated with the Centers for Medicare & Medicaid Services (CMS) conducted a study of almost 1.3 million Medicare beneficiaries. They found a positive relationship — a one-star higher rating was associated with a 9.5 percentage point increase in likelihood to enroll.
Read the full story:
Source: Kaiser Health News






